Ninety One UK Ltd Boosts Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Ninety One UK Ltd boosted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 16.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,201,198 shares of the medical instruments supplier’s stock after purchasing an additional 166,963 shares during the period. Ninety One UK Ltd owned about 0.57% of DENTSPLY SIRONA worth $42,751,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. MetLife Investment Management LLC raised its stake in shares of DENTSPLY SIRONA by 23.1% in the first quarter. MetLife Investment Management LLC now owns 59,453 shares of the medical instruments supplier’s stock valued at $2,926,000 after buying an additional 11,156 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in shares of DENTSPLY SIRONA by 6.6% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 29,250 shares of the medical instruments supplier’s stock valued at $1,440,000 after buying an additional 1,811 shares during the period. Raymond James Trust N.A. raised its stake in shares of DENTSPLY SIRONA by 61.7% during the 1st quarter. Raymond James Trust N.A. now owns 7,042 shares of the medical instruments supplier’s stock valued at $346,000 after purchasing an additional 2,687 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of DENTSPLY SIRONA by 6.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,833,372 shares of the medical instruments supplier’s stock valued at $90,243,000 after purchasing an additional 117,571 shares during the period. Finally, Sei Investments Co. raised its stake in shares of DENTSPLY SIRONA by 18.9% during the 1st quarter. Sei Investments Co. now owns 468,759 shares of the medical instruments supplier’s stock valued at $23,090,000 after purchasing an additional 74,629 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Wall Street Analyst Weigh In

XRAY has been the topic of a number of analyst reports. Needham & Company LLC reiterated a “buy” rating and set a $42.00 price objective on shares of DENTSPLY SIRONA in a research note on Thursday, February 29th. Leerink Partnrs reiterated an “outperform” rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday, January 19th. Piper Sandler upped their target price on DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a “neutral” rating in a research note on Friday, January 12th. Finally, SVB Leerink initiated coverage on DENTSPLY SIRONA in a research note on Monday, February 26th. They issued an “outperform” rating and a $42.00 target price on the stock. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $39.50.

DENTSPLY SIRONA Price Performance

XRAY opened at $30.44 on Friday. The stock has a 50-day moving average price of $32.84 and a 200-day moving average price of $32.87. DENTSPLY SIRONA Inc. has a 12-month low of $26.27 and a 12-month high of $43.24. The company has a current ratio of 1.38, a quick ratio of 0.95 and a debt-to-equity ratio of 0.55. The stock has a market capitalization of $6.31 billion, a P/E ratio of -49.10, a PEG ratio of 1.23 and a beta of 0.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.01. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The firm had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $972.61 million. During the same period in the prior year, the business earned $0.46 EPS. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year. Equities analysts predict that DENTSPLY SIRONA Inc. will post 2.05 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were issued a $0.16 dividend. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.10%. The ex-dividend date of this dividend was Wednesday, March 27th. DENTSPLY SIRONA’s dividend payout ratio is presently -103.23%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.